Corinde Staring
Associate Director Evidence Generation Genmab
Corinde Staring is Associate Director of Evidence Generation at Genmab, where she leads the execution of global Medical Affairs programmes across both pipeline and approved products. With a strong background in clinical operations and managed access, she brings extensive experience in post-trial access, pre-approval access, and investigator-sponsored research. Corinde specialises in delivering complex global programmes, aligning cross-functional teams, and ensuring high-quality, compliant execution across the full lifecycle of access and evidence generation initiatives.
Seminars
Tuesday 20th October 2026
Panel Discussion: Driving Smarter Decisions by Clarifying the Role of RWD in Early Access Programmes
3:30 pm
- Comparing how FDA, EMA, and national health authorities interpret the use of RWD in expanded and post-trial access programs
- Examining differing company approaches, from limiting programs to treatment-only access to actively incorporating structured evidence generation
- Exploring real-world examples of where regulators accepted or rejected RWD submissions in filings and approvals
- Defining the boundaries of ethical and compliant RWD collection when patient care is the primary purpose
Wednesday 21st October 2026
Remediating Access Programmes Following Acquisitions or Organisational Change
11:30 am
- Assessing inherited access programmes against internal standards without interrupting treatment
- Prioritising remediation activities while maintaining non-negotiable patient continuity
- Aligning governance, documentation, and vendors under a new operating model
- Managing internal risk and accountability during programme integration
